Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Muggia

Showing results (201-210 of 317) with videos related to

Pageof 32
Sort By:
Cancer|February 1, 1981
Clinical trials with the hexitol derivatives in the U.SD F Chiuten, M Rozencweig, D D Von Hoff, et al.
Cancer Research|March 1, 1971
Clinical studies with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037)H H Hansen, O S Selawry, F M Muggia, et al.
Cancer|July 1, 1977
VM 26 and VP 16-213: a comparative analysisM Rozencweig, D D Von Hoff, J E Henney, et al.
The New England Journal of Medicine|February 24, 1977
Tuftsin - unimportant or forgotten?S W Mikulski, D D Von Hoff, M Rozencweig, et al.
Archiv Fur Geschwulstforschung|January 1, 1978
Current trends and prospects in surgical adjuvant trialsM Rozencweig, D D von Hoff, A C Louie, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
N-(Phosphonacetyl)-L-aspartate (PALA): current statusM Rozencweig, R Abele, M Piccart, et al.
Cancer Treatment and Research|January 1, 1995
Aspects of one-carbon folate cycling related to fluoropyrimidine and antifolate therapyC P Spears, G Carlsson, F M Muggia, et al.
Cancer Treatment Reports|September 1, 1987
Phase II trial of oral methotrexate and dipyridamole in colorectal carcinomaS Wadler, M Subar, M D Green, et al.
Pharmacology & Therapeutics|January 1, 1990
Evidence of the selective alteration of anthracycline activity due to modulation by ICRF-187 (ADR-529)M D Green, P Alderton, J Gross, et al.
Radiology|November 1, 1975
Radiation-related eosinophilia. Correlation with delayed hypersensitivity, lymphocyte count, and survival in patients treated by curative radiotherapyN A Ghossein, J L Bosworth, P Stacey, et al.
Pageof 32

Showing results (201-210 of 317) with videos related to

Sort By:
Pageof 32
Cancer|February 1, 1981
Clinical trials with the hexitol derivatives in the U.SD F Chiuten, M Rozencweig, D D Von Hoff, et al.
Cancer Research|March 1, 1971
Clinical studies with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037)H H Hansen, O S Selawry, F M Muggia, et al.
Cancer|July 1, 1977
VM 26 and VP 16-213: a comparative analysisM Rozencweig, D D Von Hoff, J E Henney, et al.
The New England Journal of Medicine|February 24, 1977
Tuftsin - unimportant or forgotten?S W Mikulski, D D Von Hoff, M Rozencweig, et al.
Archiv Fur Geschwulstforschung|January 1, 1978
Current trends and prospects in surgical adjuvant trialsM Rozencweig, D D von Hoff, A C Louie, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
N-(Phosphonacetyl)-L-aspartate (PALA): current statusM Rozencweig, R Abele, M Piccart, et al.
Cancer Treatment and Research|January 1, 1995
Aspects of one-carbon folate cycling related to fluoropyrimidine and antifolate therapyC P Spears, G Carlsson, F M Muggia, et al.
Cancer Treatment Reports|September 1, 1987
Phase II trial of oral methotrexate and dipyridamole in colorectal carcinomaS Wadler, M Subar, M D Green, et al.
Pharmacology & Therapeutics|January 1, 1990
Evidence of the selective alteration of anthracycline activity due to modulation by ICRF-187 (ADR-529)M D Green, P Alderton, J Gross, et al.
Radiology|November 1, 1975
Radiation-related eosinophilia. Correlation with delayed hypersensitivity, lymphocyte count, and survival in patients treated by curative radiotherapyN A Ghossein, J L Bosworth, P Stacey, et al.
Pageof 32